Literature DB >> 23962087

Interaction of 14-3-3ζ with microtubule-associated protein tau within Alzheimer's disease neurofibrillary tangles.

Hamid Y Qureshi1, Tong Li, Ryen MacDonald, Chul Min Cho, Nicole Leclerc, Hemant K Paudel.   

Abstract

Alzheimer's disease (AD) is characterized by the presence of abnormal, straight filaments and paired helical filaments (PHFs) that are coated with amorphous aggregates. When PHFs are treated with alkali, they untwist and form filaments with a ribbonlike morphology. Tau protein is the major component of all of these ultrastructures. 14-3-3ζ is present in NFTs and is significantly upregulated in AD brain. The molecular basis of the association of 14-3-3ζ within NFTs and the pathological significance of its association are not known. In this study, we have found that 14-3-3ζ is copurified and co-immunoprecipitates with tau from NFTs of AD brain extract. In vitro, tau binds to both phosphorylated and nonphosphorylated tau. When incubated with 14-3-3ζ, tau forms amorphous aggregates, single-stranded, straight filaments, ribbonlike filaments, and PHF-like filaments, all of which resemble the corresponding ultrastructures found in AD brain. Immuno-electron microscopy determined that both tau and 14-3-3ζ are present in these ultrastructures and that they are formed in an incubation time-dependent manner. Amorphous aggregates are formed first. As the incubation time increases, the size of amorphous aggregates increases and they are incorporated into single-stranded filaments. Single-stranded filaments laterally associate to form double-stranded, ribbonlike, and PHF-like filaments. Both tau and phosphorylated tau aggregate in a similar manner when they are incubated with 14-3-3ζ. Our data suggest that 14-3-3ζ has a role in the fibrillization of tau in AD brain, and that tau phosphorylation does not affect 14-3-3ζ-induced tau aggregation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23962087     DOI: 10.1021/bi400442d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

Review 1.  14-3-3/Tau Interaction and Tau Amyloidogenesis.

Authors:  Yuwen Chen; Xingyu Chen; Zhiyang Yao; Yuqi Shi; Junwen Xiong; Jingjing Zhou; Zhengding Su; Yongqi Huang
Journal:  J Mol Neurosci       Date:  2019-05-06       Impact factor: 3.444

2.  CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation.

Authors:  Yazi D Ke; Gabriella Chan; Kristie Stefanoska; Carol Au; Mian Bi; Julius Müller; Magdalena Przybyla; Astrid Feiten; Emmanuel Prikas; Glenda M Halliday; Olivier Piguet; Matthew C Kiernan; Michael Kassiou; John R Hodges; Clement T Loy; John S Mattick; Arne Ittner; Jillian J Kril; Greg T Sutherland; Lars M Ittner
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

Review 3.  Role of RAGE in Alzheimer's Disease.

Authors:  Zhiyou Cai; Nannuan Liu; Chuanling Wang; Biyong Qin; Yingjun Zhou; Ming Xiao; Liying Chang; Liang-Jun Yan; Bin Zhao
Journal:  Cell Mol Neurobiol       Date:  2015-07-15       Impact factor: 5.046

4.  Downregulation of 14-3-3 Proteins in Alzheimer's Disease.

Authors:  Qiang Gu; Elvis Cuevas; James Raymick; Jyotshna Kanungo; Sumit Sarkar
Journal:  Mol Neurobiol       Date:  2019-09-05       Impact factor: 5.590

Review 5.  Emerging modes-of-action in drug discovery.

Authors:  Eric Valeur; Frank Narjes; Christian Ottmann; Alleyn T Plowright
Journal:  Medchemcomm       Date:  2019-06-25       Impact factor: 3.597

6.  Histone deacetylase 6 (HDAC6) promotes the pro-survival activity of 14-3-3ζ via deacetylation of lysines within the 14-3-3ζ binding pocket.

Authors:  Jeffrey B Mortenson; Lisa N Heppler; Courtney J Banks; Vajira K Weerasekara; Matthew D Whited; Stephen R Piccolo; William E Johnson; J Will Thompson; Joshua L Andersen
Journal:  J Biol Chem       Date:  2015-03-13       Impact factor: 5.157

Review 7.  Traumatic MicroRNAs: Deconvolving the Signal After Severe Traumatic Brain Injury.

Authors:  Martin Cente; Katarina Matyasova; Nikoleta Csicsatkova; Adela Tomikova; Sara Porubska; Yun Niu; Marek Majdan; Peter Filipcik; Igor Jurisica
Journal:  Cell Mol Neurobiol       Date:  2022-07-19       Impact factor: 4.231

8.  Similarity search combined with docking and molecular dynamics for novel hAChE inhibitor scaffolds.

Authors:  Nadia Melo Borges; Geraldo Rodrigues Sartori; Jean F R Ribeiro; Josmar R Rocha; João B L Martins; Carlos A Montanari; Ricardo Gargano
Journal:  J Mol Model       Date:  2018-01-13       Impact factor: 1.810

Review 9.  14-3-3 Proteins: Novel Pharmacological Targets in Neurodegenerative Diseases.

Authors:  F Sanders Pair; Talene A Yacoubian
Journal:  Trends Pharmacol Sci       Date:  2021-01-28       Impact factor: 14.819

10.  Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.

Authors:  María Victoria Zelaya; Estela Pérez-Valderrama; Xabier Martínez de Morentin; Teresa Tuñon; Isidro Ferrer; María Rosario Luquin; Joaquín Fernandez-Irigoyen; Enrique Santamaría
Journal:  Oncotarget       Date:  2015-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.